274 related articles for article (PubMed ID: 31119052)
21. Risk Factors for Cervical Lymph Node Metastasis of Papillary Thyroid Microcarcinoma: A Single-Center Retrospective Study.
Cheng F; Chen Y; Zhu L; Zhou B; Xu Y; Chen Y; Wen L; Chen S
Int J Endocrinol; 2019; 2019():8579828. PubMed ID: 30774660
[TBL] [Abstract][Full Text] [Related]
22. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
Back K; Kim JS; Kim JH; Choe JH
Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121
[TBL] [Abstract][Full Text] [Related]
23. Outcome of papillary thyroid microcarcinoma: Study of 1,990 cases.
Lu ZZ; Zhang Y; Wei SF; Li DS; Zhu QH; Sun SJ; Li M; Li LI
Mol Clin Oncol; 2015 May; 3(3):672-676. PubMed ID: 26137285
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological Findings Associated With Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study in China.
Shi Y; Yang Z; Heng Y; Ju H; Pan Y; Zhang Y
Cancer Control; 2022; 29():10732748221084926. PubMed ID: 35285273
[TBL] [Abstract][Full Text] [Related]
25. Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis.
Qu N; Zhang L; Ji QH; Chen JY; Zhu YX; Cao YM; Shen Q
World J Surg; 2015 Oct; 39(10):2459-70. PubMed ID: 26099728
[TBL] [Abstract][Full Text] [Related]
26. Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma.
Lin DZ; Qu N; Shi RL; Lu ZW; Ji QH; Wu WL
Onco Targets Ther; 2016; 9():5307-16. PubMed ID: 27601922
[TBL] [Abstract][Full Text] [Related]
27. A prediction model incorporating the BRAF
Liu S; Liu C; Zhao L; Wang K; Li S; Tian Y; Jiao B; Gui Z; Yu T; Zhang L
Eur J Surg Oncol; 2021 Nov; 47(11):2774-2780. PubMed ID: 34483032
[TBL] [Abstract][Full Text] [Related]
28. Associations of BRAF V600E, clinical pathology and imaging factors with the recurrence rate of papillary thyroid microcarcinoma.
Huang K; Gao N; Bian D; Zhai Q; Yang P; Zhang Y
Exp Ther Med; 2020 Dec; 20(6):243. PubMed ID: 33178341
[TBL] [Abstract][Full Text] [Related]
29. Risk Factors for Central and Lateral Lymph Node Metastases in Patients With Papillary Thyroid Micro-Carcinoma: Retrospective Analysis on 484 Cases.
Huang Y; Yin Y; Zhou W
Front Endocrinol (Lausanne); 2021; 12():640565. PubMed ID: 33746905
[TBL] [Abstract][Full Text] [Related]
30. Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study.
Zhou YL; Gao EL; Zhang W; Yang H; Guo GL; Zhang XH; Wang OC
World J Surg Oncol; 2012 May; 10():67. PubMed ID: 22540396
[TBL] [Abstract][Full Text] [Related]
31. The synergic effect of BRAF
Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
[TBL] [Abstract][Full Text] [Related]
32. Risk Factor Analysis for Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.
Liu W; Wang S; Xia X
Int J Gen Med; 2021; 14():9923-9929. PubMed ID: 34949939
[TBL] [Abstract][Full Text] [Related]
33. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases.
Zhang Q; Wang Z; Meng X; Duh QY; Chen G
Asian J Surg; 2019 Apr; 42(4):571-576. PubMed ID: 30348606
[TBL] [Abstract][Full Text] [Related]
34. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
[TBL] [Abstract][Full Text] [Related]
35. Predictive Value of Ultrasound Imaging Characteristics and a BRAF V600E Nomogram for Central Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.
Zhu D; Wu X; Zhang L; Chen Z
Altern Ther Health Med; 2023 Nov; 29(8):139-143. PubMed ID: 37632946
[TBL] [Abstract][Full Text] [Related]
36. Independent Risk Factors Predicting Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.
Yu X; Song X; Sun W; Zhao S; Zhao J; Wang YG
Horm Metab Res; 2017 Mar; 49(3):201-207. PubMed ID: 28351086
[TBL] [Abstract][Full Text] [Related]
37. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
38. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
39. Value of Combining Clinical Factors, Conventional Ultrasound, and Contrast-Enhanced Ultrasound Features in Preoperative Prediction of Central Lymph Node Metastases of Different Sized Papillary Thyroid Carcinomas.
Wang Y; Nie F; Wang G; Liu T; Dong T; Sun Y
Cancer Manag Res; 2021; 13():3403-3415. PubMed ID: 33907464
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of risk factors for central lymph node metastasis in papillary thyroid microcarcinoma].
Wang ZH; Zhang YJ; Fu GM; Chen YB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):12-17. PubMed ID: 30704163
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
